TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
CHE

Chemed Corp

Healthcare · Medical Care Facilities

534.70$ -1.3% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns Chemed Corp (CHE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 90.7% of the shares are freely tradable; institutional investors hold 104.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 104.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 90.7%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 5.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 13Mio.

Largest Shareholders

Institutions

Institutions CHE
Name Stake (%) Shares Change (%) Date
BlackRock Inc 11.36 1,484,282 +11.0 06/30/2026
AQR Capital Management LLC 7.44 972,474 +134.0 06/30/2026
Vanguard Portfolio Management, LLC 6.02 787,068 -3.5 06/30/2026
Vanguard Capital Management, LLC 4.62 604,420 -5.0 06/30/2026
Acadian Asset Management LLC 3.47 453,238 +47.7 06/30/2026
State Street Corp 3.40 444,716 -3.8 06/30/2026
Geode Capital Management, LLC 3.17 413,942 +0.7 06/30/2026
JPMorgan Chase & Co 3.09 403,395 -19.5 06/30/2026

Funds

Funds CHE
Name Stake (%) Shares Change (%) Date
iShares Core S&P Mid-Cap ETF 3.56 465,608 +0.0 09/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.17 414,420 -2.9 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings CHE
Person Role Shares Value As of Type
Mcnamara Kevin J president and CEO 66,418 35,513,705 $ Sep 28, 2026 direct
Hutton Thomas C vice president 32,840 17,559,548 $ Sep 28, 2026 direct
Lee Spencer S executive vice president 14,851 7,940,830 $ Sep 30, 2026 direct
Grace Patrick P Director 3,533 1,889,095 $ Jul 31, 2026 direct
Judkins Brian C VP and Chief Legal Officer 3,344 1,788,037 $ Aug 10, 2026 direct
Wherley Joel L CEO - Vitas Healthcare 1,181 631,481 $ Aug 5, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 30, 2026 Lee Spencer S executive vice president Other 11,160 508.93 5,679,659
Sep 30, 2026 Lee Spencer S executive vice president Other 12,099 445.35 5,388,290
Sep 28, 2026 Mcnamara Kevin J president and CEO Sell 2,000 513.45 1,026,900
Sep 28, 2026 Hutton Thomas C vice president Other 4,270 506.65 2,163,396
Sep 28, 2026 Hutton Thomas C vice president Other 4,629 445.35 2,061,525
Sep 18, 2026 Mcnamara Kevin J president and CEO Sell 2,000 501.40 1,002,800
Aug 21, 2026 Lee Spencer S executive vice president Sell 1,000 541.04 541,040
Aug 21, 2026 Mcnamara Kevin J president and CEO Sell 2,000 541.16 1,082,320
Aug 10, 2026 Judkins Brian C VP and Chief Legal Officer Other 5,878 548.96 3,226,787
Aug 10, 2026 Judkins Brian C VP and Chief Legal Officer Other 6,786 445.35 3,022,145
Aug 5, 2026 Wherley Joel L CEO - Vitas Healthcare Other 2,270 542.62 1,231,747
Aug 5, 2026 Wherley Joel L CEO - Vitas Healthcare Other 2,599 445.35 1,157,465
Aug 3, 2026 Mcnamara Kevin J president and CEO Sell 2,000 539.51 1,079,020
Jul 31, 2026 Mcnamara Kevin J president and CEO Other 19,802 529.22 10,479,614
Jul 31, 2026 Mcnamara Kevin J president and CEO Other 2,001 445.35 891,145
Jul 31, 2026 Grace Patrick P Director Sell 190 532.00 101,080

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?